Carroll R C, Worthington R E, Boucheix C
Department of Medical Biology, University of Tennessee Medical Center, Knoxville 37920.
Biochem J. 1990 Mar 1;266(2):527-35. doi: 10.1042/bj2660527.
The CD9 molecule is a 24 kDa surface-membrane glycoprotein present on platelets and a variety of haematopoetic and non-haematopoetic tissues. In the present study we utilized specific inhibitors of thromboxane A2 (TxA2) formation (aspirin), protein kinase C [H-7 [1-(5-isoquinolinesulphonyl)-2-methylpiperazine]] and autocrine stimulation by secreted ADP (apyrase) to modify platelet activation by a monoclonal antibody ALB-6 to the CD9 antigen. This activation is only partially inhibited by aspirin alone but, in combination with either H-7 or apyrase, more than 50% inhibition of platelet aggregation and secretion was observed. This combination of inhibitors was also required to inhibit effectively the phosphorylation of myosin light chain and the 47 kDa substrate of protein kinase C. Intracellular Ca2+ flux monitored by the fluorescent dye fura-2 showed that this was almost completely mediated by the aspirin-sensitive TxA2 pathway. We suggest that the aspirin-insensitive pathway is primarily mediated by phospholipase C formation of diacylglycerol to activate protein kinase C. The inhibition by apyrase suggests a strong dependency on autocrine stimulation by secreted ADP to fully activate both phospholipase C and express fibrinogen-binding sites mediating platelet aggregation. This alternate pathway of phospholipase C activation by ALB-6 may be mediated by cytoplasmic alkalinization [monitored by SNARF-1 (5'(6')-carboxy-10-bismethylamino-3-hydroxy-spiro-[7H- benzo[c]xanthine-1',7(3H)-isobenzofuran]-3'-one) fluorescence of the dye]. Both activation pathways are dependent on intact antibodies, since F(ab')2 fragments of SYB-1, a monoclonal antibody against the CD9 antigen with activation characteristics identical with those of ALB-6, do not elicit activation. Besides thrombin, collagen is another physiological agonist shown to induce aspirin-insensitive activation. Similarities to ALB-6 in collagen sensitivity to apyrase in combination with aspirin inhibitors were noted with respect to aggregation and secretion, as well as a complete block of Ca2+ flux by aspirin. However, it is unlikely that collagen activation is mediated by the CD9 antigen, since SYB-1 F(ab')2 fragments had no effect on collagen activation and aspirin also completely blocked the alkalinization response to collagen, in contrast with ALB-6.
CD9分子是一种24 kDa的表面膜糖蛋白,存在于血小板以及多种造血和非造血组织中。在本研究中,我们使用了血栓素A2(TxA2)形成的特异性抑制剂(阿司匹林)、蛋白激酶C [H-7 [1-(5-异喹啉磺酰基)-2-甲基哌嗪]] 以及分泌型ADP的自分泌刺激(腺苷三磷酸双磷酸酶),来改变单克隆抗体ALB-6对CD9抗原介导的血小板活化。单独使用阿司匹林只能部分抑制这种活化,但与H-7或腺苷三磷酸双磷酸酶联合使用时,可观察到血小板聚集和分泌的抑制率超过50%。还需要这种抑制剂组合来有效抑制肌球蛋白轻链和蛋白激酶C的47 kDa底物的磷酸化。用荧光染料fura-2监测细胞内Ca2+通量表明,这几乎完全由对阿司匹林敏感的TxA2途径介导。我们认为,对阿司匹林不敏感的途径主要由磷脂酶C形成二酰甘油来激活蛋白激酶C介导。腺苷三磷酸双磷酸酶的抑制表明强烈依赖分泌型ADP的自分泌刺激来完全激活磷脂酶C并表达介导血小板聚集的纤维蛋白原结合位点。ALB-6激活磷脂酶C的这种替代途径可能由细胞质碱化介导 [通过染料SNARF-1(5'(6')-羧基-10-双甲基氨基-3-羟基-螺-[7H-苯并[c]呫吨-1',7(3H)-异苯并呋喃]-3'-酮)荧光监测]。两种激活途径都依赖完整的抗体,因为针对CD9抗原的具有与ALB-6相同激活特性的单克隆抗体SYB-1的F(ab')2片段不会引发激活。除了凝血酶外,胶原蛋白是另一种显示可诱导对阿司匹林不敏感激活的生理激动剂。在聚集和分泌方面,以及阿司匹林对Ca2+通量的完全阻断方面,注意到胶原蛋白对腺苷三磷酸双磷酸酶与阿司匹林抑制剂联合使用的敏感性与ALB-6相似。然而,胶原蛋白激活不太可能由CD9抗原介导,因为SYB-1 F(ab')2片段对胶原蛋白激活没有影响,并且与ALB-6相反,阿司匹林也完全阻断了对胶原蛋白的碱化反应。